Academic medicine: time for reinvention

BMJ 2004; 328 doi: 10.1136/bmj.328.7430.49 (Published 1 January 2004)
Cite this as: BMJ 2004;328:49.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

MRC aims to give NHS evidence from randomised clinical trials

  1. Colin Blakemore, chief executive (colin.blakemore@headoffice.mrc.ac.uk),
  2. Iain Chalmers, coordinator (ichalmers@jameslindlibrary.org)
  1. Medical Research Council, London W1B 1AL
  2. James Lind Initiative, Oxford OX2 7LG

    EDITOR—The public in general and NHS patients in particular ought to benefit from advances in knowledge about prevention, treatment, rehabilitation, and care. Important progress has been made in disseminating relevant information through the National Electronic Library for Health and the National Institute for Clinical Excellence (NICE), but more investment in randomised clinical trials is needed to …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL